Engaging dystonia networks with subthalamic stimulation

K Konstantin Butenko (Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School) C Clemens Neudorfer (Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School) T Till A. Dembek (Department of Neurology, Faculty of Medicine, University of Cologne) B Barbara Hollunder (Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin) G Garance M. Meyer (Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School) N Ningfei Li (Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin) S Simón Oxenford (Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin) B Bahne H. Bahners (Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School) B Bassam Al-Fatly (Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin) R Roxanne Lofredi (Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin) E Evan M. Gordon N Nico U. F. Dosenbach C Christos Ganos (Movement Disorder Clinic, Edmond J. Safra Program in Parkinson’s Disease, Division of Neurology, University of Toronto, Toronto Western Hospital) M Mark Hallett (Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH) H Hyder A. Jinnah (Department of Neurology, Emory University) P Philip A. Starr J Jill L. Ostrem (Movement Disorders and Neuromodulation Centre, Department of Neurology, University of California) Y Yiwen Wu (Department of Neurology & Institute of Neurology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine) C Chencheng Zhang M Michael D. Fox A Andreas Horn

Abstract

Deep brain stimulation is an efficacious treatment for dystonia. While the internal pallidum serves as the primary target, recently, stimulation of the subthalamic nucleus (STN) has been investigated. However, optimal targeting within this structure and its surroundings have not been studied in depth. Indeed, historical targets that have been used for surgical treatment of dystonia are directly adjacent to the STN. Further, multiple types of dystonia exist, and outcomes are variable, suggesting that not all types would profit maximally from the same target. Therefore, a thorough investigation of neural substrates underlying stimulation effects on dystonia signs and symptoms is warranted. Here, we analyze a multicenter cohort of isolated dystonia patients with subthalamic implantations ( N = 58) and relate their stimulation sites to improvements of appendicular and cervical symptoms as well as blepharospasm. Stimulation of the ventral oral posterior nucleus of thalamus and surrounding regions were associated with improvements in cervical dystonia, while stimulation of the dorsolateral STN was associated with improvements in limb dystonia and blepharospasm. This dissociation was matched by structural connectivity analysis, where the cerebellothalamic, corticospinal, and pallidosubthalamic tracts were associated with improvements of cervical dystonia, while hyperdirect and subthalamopallidal pathways with alleviation of limb dystonia and blepharospasm. On the level of functional networks, improvements of limb dystonia were associated with connectivity to the corresponding somatotopic regions in the primary motor cortex, while alleviation of cervical dystonia to the cingulo-opercular network. These findings shed light on the pathophysiology of dystonia and may guide DBS targeting and programming in the future.

Article Details

Volume / Issue Vol. 122, Issue 2
Published January 14, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (21)

K

Konstantin Butenko

Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School

C

Clemens Neudorfer

Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School

T

Till A. Dembek

Department of Neurology, Faculty of Medicine, University of Cologne

B

Barbara Hollunder

Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin

G

Garance M. Meyer

Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School

N

Ningfei Li

Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin

S

Simón Oxenford

Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin

B

Bahne H. Bahners

Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women’s Hospital, Harvard Medical School

B

Bassam Al-Fatly

Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin

R

Roxanne Lofredi

Movement Disorders and Neuromodulation Unit, Department of Neurology, Charité—Universitätsmedizin Berlin

E

Evan M. Gordon

N

Nico U. F. Dosenbach

C

Christos Ganos

Movement Disorder Clinic, Edmond J. Safra Program in Parkinson’s Disease, Division of Neurology, University of Toronto, Toronto Western Hospital

M

Mark Hallett

Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH

H

Hyder A. Jinnah

Department of Neurology, Emory University

P

Philip A. Starr

J

Jill L. Ostrem

Movement Disorders and Neuromodulation Centre, Department of Neurology, University of California

Y

Yiwen Wu

Department of Neurology & Institute of Neurology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine

C

Chencheng Zhang

M

Michael D. Fox

A

Andreas Horn